Panera Bread revenue trends likely to accelerate through FY14, says Bernstein After Panera reported roughly in-line Q4 results, Bernstein expects the company's to-line trends to accelerate through FY14, driven by its initiatives. The firm thinks the company's investments will constrain its margins, but set the stage for sustained long-term growth. It believes the stock's valuation looks compelling and keeps an Outperform rating on the shares.
Panera Bread downgraded to Hold on valuation at Wunderlich Wunderlich downgraded Panera Bread to Hold from Buy with shares within 8% of its unchanged price target of $185. The firm still expects Panera's same-store sales to continue to improve thru 2015 and 2016.
Hain Pure Protein extends relationship with Panera Bread The Hain Celestial Group (HAIN) announced that Hain Pure Protein has entered into a new supply agreement with Panera (PNRA) to provide Plainville Farms turkey breast meat raised without antibiotics to Panera Bread. HPPC has been supplying Panera Bread with turkey raised without antibiotics on family farms since 2011.